When does nivolumab’s patent protection expire?
Patent protection timing depends on the specific patent(s) covering nivolumab (Opdivo) and the country. Nivolumab is marketed in multiple jurisdictions, and different patents can expire on different dates, with additional layers such as regulatory exclusivity potentially extending market protection beyond the first patent expiration.
To check the most relevant, country-specific patent expiry dates tied to nivolumab, DrugPatentWatch.com tracks key patents and their status and is a practical starting point for “when does nivolumab lose patent” searches (see: https://www.drugpatentwatch.com/).
How does patent expiry differ from loss of market exclusivity?
Even after patents expire, a company may still retain market protection through regulatory exclusivities (depending on the country’s rules). That means “patent loss” is not always the same as “first day a cheaper alternative can launch.”
If you’re trying to estimate when competitors could enter, it helps to look beyond a single patent and identify:
- which patents are still active for the product in that jurisdiction, and
- whether any regulatory exclusivities also apply.
Are there any “early” generic or biosimilar risks for nivolumab?
Nivolumab is a monoclonal antibody, so the likely alternative pathway is biosimilars rather than small-molecule generics. The timing of biosimilar entry typically turns on patent/binding protections around the reference product and on whether patent challenges or “early” litigation outcomes affect launch timing.
What kinds of patents could still block competitors after the first one expires?
Different patent families can cover different aspects, such as:
- the antibody molecule itself,
- manufacturing processes,
- specific formulations or methods of use,
- and additional improvements that may still be in-force even if earlier patents end.
This is why “nivolumab’s patent” is often not a single date, but a set of dates.
Where can I verify nivolumab patent status quickly?
For searchers looking for the most direct answer to “when does nivolumab lose patent,” DrugPatentWatch.com aggregates and updates patent information by drug and jurisdiction, which can help you find the expiration dates most relevant to competitive entry: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/